NOTICENCT04140344
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
At risk: Primary completion moved at least 31 days later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 23 versions: 21 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 14 words Show 4 more changesShow less
- Primary completion pushed from Oct 2026 to Dec 2026
- Study completion pushed from Oct 2027 to Dec 2027
- Secondary endpoints: details revised at 2 of 3 entries
- Site contact updated
- Notable Primary completion date: Oct 2025 to Oct 2026
- Study completion date: Oct 2026 to Oct 2027
- Notable Primary completion date: Oct 2024 to Oct 2025
- Study completion date: Oct 2024 to Oct 2026
Notable Trial status: Not Yet Recruiting to Recruitingv18 Show 4 more changesShow less
- Enrollment target: 448 to 224
- Start date changed from estimate of Oct 1, 2023 to Sep 7, 2023
- Study description revised
- Site details revised
- Notable Start date: Jun 1, 2023 to Oct 1, 2023
- Primary and study completion dates: Jun 2024 to Oct 2024
Show 15 earlier versionsHide 15 earlier versions
Notable Start date: Apr 1, 2023 to Jun 1, 2023v16 Show 4 more changesShow less
- Primary endpoint revised
- Primary and study completion dates: Apr 2024 to Jun 2024
- Secondary endpoints revised (3)
- Site contact updated
- Notable Start date: Feb 1, 2023 to Apr 1, 2023
- Primary and study completion dates: Feb 2024 to Apr 2024
- Notable Start date: Nov 1, 2022 to Feb 1, 2023v14
- Notable Start date: Sep 1, 2022 to Nov 1, 2022v13
- Notable Start date: Jul 1, 2022 to Sep 1, 2022v12
- Notable Start date: Apr 1, 2022 to Jul 1, 2022v11
- Notable Start date: Jan 22, 2022 to Apr 1, 2022v10
- Notable Primary and study completion dates: Feb 2023 to Feb 2024
- Start date: Nov 22, 2021 to Jan 22, 2022
- Notable Start date: Oct 16, 2021 to Nov 22, 2021v8
- Notable Start date: Aug 16, 2021 to Oct 16, 2021v7
- Notable Start date: Jul 1, 2021 to Aug 16, 2021v6
- Notable Start date: Apr 2021 to Jul 1, 2021v5
- Notable Start date: Jan 2021 to Apr 2021v4
- Notable Start date: Apr 2020 to Jan 2021v3
- Notable Start date: Jan 2020 to Apr 2020
- Secondary endpoints revised (3)
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (3)
Arms and interventions
The intervention group will receive automated text messages every day for the first week, and every other day for the second week post-operatively. The text messages will follow a series of pre-defined standardized scripts (Appendix 3) with embedded hyperlinks to a video from the providers with further advice. The patient is directed not to respond to the text messages, but to call for any questions or concerns. The text message group will receive a 30-day post-operative phone call to evaluate: number of ED visits, hospital readmissions, and to re-administer the questionnaires completed at baseline visit. Other data to be collected may include the following: number of phone calls to provider, MyChart messages to provider, pain medications, and new problems like pain and infection.
The control group will be given the standard post-op packet that includes detailed instructions on proper wound care and signs and symptoms of infection. They will not receive text messages. The same outcomes will be assessed in both groups through a 30-day post-operative phone call.
Other: Text Message Group
Sites
1 site in 1 country
- Duke Neurosurgery and Duke OrthopedicsDurham, North Carolina, United States